Evidence map›Paper›PMID 41821079›Full record

ArticleSubstance abuse treatment, prevention, and policy2026

Lessons from COVID-19: Perspectives of senior managers and decision-makers in substance use services in Wales.

Shannon Murray, Katy Holloway, Marian Buhociu, Martin Blakebrough, Caroline Phipps

Abstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shannon MurrayUniversity of South Wales, Llantwit Rd, Treforest, Pontypridd, CF37 1DL, UK. Shannon.murray@southwales.ac.uk.
Katy HollowayUniversity of South Wales, Llantwit Rd, Treforest, Pontypridd, CF37 1DL, UK.
Marian BuhociuUniversity of South Wales, Llantwit Rd, Treforest, Pontypridd, CF37 1DL, UK.
Martin BlakebroughKaleidoscope, Cardiff, UK.
Caroline PhippsBarod, Newport, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic significantly disrupted substance use services, potentially exacerbating existing inequities in access to treatment. This study examines the perspectives of senior managers and decision-makers in Wales regarding equity issues in substance use services during the pandemic.

methodsSemi-structured interviews were conducted with fifteen senior managers and decision-makers from various organisations in the substance use field in Wales. Interviews were conducted during autumn 2020. Data were analysed using reflexive thematic analysis to identify key themes related to equity in access to treatment.

resultsKey findings highlighted significant disparities between third sector and statutory NHS services, particularly in access to PPE, and recognition as essential workers. The rapid shift to digital service provision exposed a digital divide, potentially excluding vulnerable service users. However, the pandemic also accelerated innovations in service delivery, such as the introduction of long-acting injectable buprenorphine and revised take-home medication policies. Long-term concerns included the economic impact on vulnerable populations, potential increases in mental health issues and substance use, and funding uncertainties for third sector services.

conclusionsThe pandemic exposed and exacerbated existing inequities in substance use services while also driving rapid innovation. Findings suggest a need for greater recognition and support for third sector services, strategies to address the digital divide, and sustained funding to ensure equitable access to treatment. These insights can inform policy and practice to develop more equitable and resilient substance use services in preparation for any future crises.

Indexed as

Administrative PersonnelCOVID-19Health Services AccessibilitySubstance-Related DisordersDecision MakingHealthcare DisparitiesHumansState MedicineWalesCOVID-19Digital divideInequitySubstance use servicesThird sectorWales

Identifiers

PMID41821079
PMCPMC12983707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.